196 related articles for article (PubMed ID: 34681758)
1. Pan-Cancer Analysis of Clinical Relevance via Telomere Maintenance Mechanism.
Sung JY; Cheong JH
Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681758
[TBL] [Abstract][Full Text] [Related]
2. Telomere maintenance mechanisms in cancer: telomerase, ALT or lack thereof.
Claude E; Decottignies A
Curr Opin Genet Dev; 2020 Feb; 60():1-8. PubMed ID: 32114293
[TBL] [Abstract][Full Text] [Related]
3. The CDKN2A G500 allele is more frequent in GBM patients with no defined telomere maintenance mechanism tumors and is associated with poorer survival.
Royds JA; Al Nadaf S; Wiles AK; Chen YJ; Ahn A; Shaw A; Bowie S; Lam F; Baguley BC; Braithwaite AW; MacFarlane MR; Hung NA; Slatter TL
PLoS One; 2011; 6(10):e26737. PubMed ID: 22046342
[TBL] [Abstract][Full Text] [Related]
4. Pan-cancer analysis of telomere maintenance mechanisms.
Hakobyan M; Binder H; Arakelyan A
J Biol Chem; 2024 May; 300(6):107392. PubMed ID: 38763334
[TBL] [Abstract][Full Text] [Related]
5. Pan-Cancer Analysis of Alternative Lengthening of Telomere Activity.
Sung JY; Lim HW; Joung JG; Park WY
Cancers (Basel); 2020 Aug; 12(8):. PubMed ID: 32784588
[TBL] [Abstract][Full Text] [Related]
6. Targeting telomeres: advances in telomere maintenance mechanism-specific cancer therapies.
Gao J; Pickett HA
Nat Rev Cancer; 2022 Sep; 22(9):515-532. PubMed ID: 35790854
[TBL] [Abstract][Full Text] [Related]
7. Telomere Maintenance Mechanisms in Cancer.
Gaspar TB; Sá A; Lopes JM; Sobrinho-Simões M; Soares P; Vinagre J
Genes (Basel); 2018 May; 9(5):. PubMed ID: 29751586
[TBL] [Abstract][Full Text] [Related]
8. The telomere maintenance mechanism spectrum and its dynamics in gliomas.
Kim S; Chowdhury T; Yu HJ; Kahng JY; Lee CE; Choi SA; Kim KM; Kang H; Lee JH; Lee ST; Won JK; Kim KH; Kim MS; Lee JY; Kim JW; Kim YH; Kim TM; Choi SH; Phi JH; Shin YK; Ku JL; Lee S; Yun H; Lee H; Kim D; Kim K; Hur JK; Park SH; Kim SK; Park CK
Genome Med; 2022 Aug; 14(1):88. PubMed ID: 35953846
[TBL] [Abstract][Full Text] [Related]
9. Telomere Length Maintenance in Cancer: At the Crossroad between Telomerase and Alternative Lengthening of Telomeres (ALT).
De Vitis M; Berardinelli F; Sgura A
Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29463031
[TBL] [Abstract][Full Text] [Related]
10. Telomere maintenance mechanism dysregulation serves as an early predictor of adjuvant therapy response and a potential therapeutic target in human cancers.
Zhang Y; Luo S; Jia Y; Zhang X
Int J Cancer; 2022 Jul; 151(2):313-327. PubMed ID: 35342938
[TBL] [Abstract][Full Text] [Related]
11. Human sarcomas are mosaic for telomerase-dependent and telomerase-independent telomere maintenance mechanisms: implications for telomere-based therapies.
Gocha AR; Nuovo G; Iwenofu OH; Groden J
Am J Pathol; 2013 Jan; 182(1):41-8. PubMed ID: 23260199
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of telomere length maintenance mechanisms in adrenocortical carcinoma.
Else T; Giordano TJ; Hammer GD
J Clin Endocrinol Metab; 2008 Apr; 93(4):1442-9. PubMed ID: 18198226
[TBL] [Abstract][Full Text] [Related]
13. Telomerase activity in pleural malignant mesotheliomas.
Au AY; Hackl T; Yeager TR; Cohen SB; Pass HI; Harris CC; Reddel RR
Lung Cancer; 2011 Sep; 73(3):283-8. PubMed ID: 21277646
[TBL] [Abstract][Full Text] [Related]
14. Telomere profiles and tumor-associated macrophages with different immune signatures affect prognosis in glioblastoma.
Hung NA; Eiholzer RA; Kirs S; Zhou J; Ward-Hartstonge K; Wiles AK; Frampton CM; Taha A; Royds JA; Slatter TL
Mod Pathol; 2016 Mar; 29(3):212-26. PubMed ID: 26769142
[TBL] [Abstract][Full Text] [Related]
15. Telomere sequence content can be used to determine ALT activity in tumours.
Lee M; Teber ET; Holmes O; Nones K; Patch AM; Dagg RA; Lau LMS; Lee JH; Napier CE; Arthur JW; Grimmond SM; Hayward NK; Johansson PA; Mann GJ; Scolyer RA; Wilmott JS; Reddel RR; Pearson JV; Waddell N; Pickett HA
Nucleic Acids Res; 2018 Jun; 46(10):4903-4918. PubMed ID: 29718321
[TBL] [Abstract][Full Text] [Related]
16. TCGA Pan-Cancer Genomic Analysis of Alternative Lengthening of Telomeres (ALT) Related Genes.
Armendáriz-Castillo I; López-Cortés A; García-Cárdenas J; Guevara-Ramírez P; Leone PE; Pérez-Villa A; Yumiceba V; Zambrano AK; Guerrero S; Paz-Y-Miño C
Genes (Basel); 2020 Jul; 11(7):. PubMed ID: 32708340
[TBL] [Abstract][Full Text] [Related]
17. Alternative Lengthening of Telomeres (ALT) in Tumors and Pluripotent Stem Cells.
Zhao S; Wang F; Liu L
Genes (Basel); 2019 Dec; 10(12):. PubMed ID: 31835618
[TBL] [Abstract][Full Text] [Related]
18. Telomeres and telomerase in head and neck squamous cell carcinoma: from pathogenesis to clinical implications.
Boscolo-Rizzo P; Da Mosto MC; Rampazzo E; Giunco S; Del Mistro A; Menegaldo A; Baboci L; Mantovani M; Tirelli G; De Rossi A
Cancer Metastasis Rev; 2016 Sep; 35(3):457-74. PubMed ID: 27501725
[TBL] [Abstract][Full Text] [Related]
19. Telomere elongation via alternative lengthening of telomeres (ALT) and telomerase activation in primary metastatic medulloblastoma of childhood.
Minasi S; Baldi C; Pietsch T; Donofrio V; Pollo B; Antonelli M; Massimino M; Giangaspero F; Buttarelli FR
J Neurooncol; 2019 May; 142(3):435-444. PubMed ID: 30830680
[TBL] [Abstract][Full Text] [Related]
20. Absence of a telomere maintenance mechanism as a favorable prognostic factor in patients with osteosarcoma.
Ulaner GA; Huang HY; Otero J; Zhao Z; Ben-Porat L; Satagopan JM; Gorlick R; Meyers P; Healey JH; Huvos AG; Hoffman AR; Ladanyi M
Cancer Res; 2003 Apr; 63(8):1759-63. PubMed ID: 12702558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
